Dotimas, Kent John S.
HRN: 12-94-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/14/2022
09/21/2022
IV
350 Mg
Q 8 HRS
Acute Suppurative Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes